Cognoptix develops non-invasive eye tests for the early diagnosis of alzheimer disease.
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 28, 2020 | Series Unknown | $2.60M | 1 | — | — | Detail |
| Oct 22, 2008 | Series B | $18.50M | 1 | — | — | Detail |
| Jan 23, 2006 | Angel | $500K | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
Rockport Venture Partners
|
— | Series B |
Granite State Angels
|
— | Angel |